951173-25-4

Basic information

• Product Name: (+/-)-(1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid
• Synonyms: (+/-)-(1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid;trans-2-{[(tert-butoxy)carbonyl]amino}cyclobutane-1-carboxylic acid;rel-(1R,2R)-2-((tert-butoxycarbonyl)amino)cyclobutane-1-carboxylic acid
• CAS NO: 951173-25-4
• Molecular Formula: C10H17NO4
• Molecular Weight: 215.24628
• Mol File: 951173-25-4.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (+/-)-(1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-(1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid(951173-25-4)
• EPA Substance Registry System: (+/-)-(1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid(951173-25-4)

Safety Data

• Hazardous Substances Data: 951173-25-4(Hazardous Substances Data)

Usage

General Description

(+/-)-(1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid is a chemical compound with the molecular formula C11H19NO4. It is a cyclobutanecarboxylic acid derivative and is commonly used as a building block in organic synthesis. The tert-butoxycarbonyl (Boc) group is a protecting group for the amino group, allowing for selective manipulation of the molecule in various reactions. The compound has potential applications in pharmaceutical and medicinal chemistry, and it is often utilized in the synthesis of peptidomimetics and other biologically active molecules. Additionally, the stereochemistry of the compound, characterized by the (1R,2R) configuration, is important for its specific chemical reactivity and biological activity.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 221158-95-8 (1R,2S)-cis-2-amino-cyclobutane-1-carboxylic acid 
• 88335-88-0 (1S,2R)-cis-2-methoxycarbonyl-cyclobutane-1-carboxylic acid 
• 84585-76-2 (+/-)-cis-2-amino-1-cyclobutanecarboxylic acid 
• 648433-09-4 (+)-(1S,2R)-2-aminocyclobutane-1-carboxylic acid 
• 951173-24-3 methyl (+)-(1S,2R)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 951173-24-3 methyl (+/-)-trans-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 951173-24-3 methyl (-)-(1R,2R)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 951173-22-1 (+)-(1S,2R)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylic acid 
• 951173-24-3 methyl (+)-trans-2-[(tert-butyloxycarbonyl)amino]cyclobutane-1-carboxylate 
• 868364-62-9 methyl (-)-(1R,2S)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 868364-63-0 (-)-(1R,2S)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylic acid 
• 402848-96-8 tert-butyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carboxylate 
• 1333084-20-0 (4S,5R)-N-[(1R,2S)-2-(t-butyloxycarbonylamino)cyclobutanecarbonyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one 

Downstream Products

• 951173-24-3 methyl (+/-)-cis-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 951173-24-3 methyl (+)-(1S,2R)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 868364-62-9 methyl (-)-(1R,2S)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 84585-76-2 (+/-)-trans-2-aminocyclobutanecarboxylic acid 
• 84585-76-2 (-)-(1R,2R)-2-aminocyclobutanecarboxylic acid 
• 84585-76-2 (+)-(1S,2S)-2-aminocyclobutanecarboxylic acid 
• 951173-24-3 methyl (-)-(1R,2R)-2-[(tert-butyloxycarbonyl)amino]cyclobutanecarboxylate 
• 951173-24-3 methyl (+)-trans-2-[(tert-butyloxycarbonyl)amino]cyclobutane-1-carboxylate 

Relevant articles and documents

Stereoselective synthesis of all stereoisomers of orthogonally protected cyclobutane-1,2-diamine and some chemoselective transformations

The four stereoisomers of protected cyclobutane-1,2-diamine have been prepared in an enantio- and diastereocontrolled manner through stereodivergent synthetic routes starting from a half-ester as a common chiral precursor. Orthogonal protection allows the

Expedient preparation of all isomers of 2-aminocyclobutanecarboxylic acid in enantiomerically pure form

A short, convenient, gram scale protocol has been established to allow facile access to all four stereoisomers of 2-ami-nocyclobutanecarboxylic acid, each in enantiomerically pure form (ee >99%). Starting from the readily available cis racemate, the proce

PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present application describes modulators of MIP-1 of formula (I) : or stereoisomers or pharmaceutically acceptable salts thereof, wherein m, Q, T, W, Z, R1, R3, R4, R5, R5a and R5b, are as set forth above. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using the modulators are disclosed.